Opérations et transactions|15 mars 2021
Greenbrook commences trading on NASDAQ
Torys acted as counsel to Greenbrook TMS with a team that included Mile Kurta, Chris Bornhorst, Robbie Leibel, David Chaikof, Rayanna Smith, Dave Marshall and Hasnaa El Rhermoul (corporate/securities), David Mattingly and Chris Saki (tax).
On March 15, 2021, Greenbrook TMS Inc. (“Greenbrook”) announced that its common shares were approved for listing and trading in U.S. dollar currency on the NASDAQ Stock Market LLC (“NASDAQ”). Trading commenced at the start of trading on March 16, 2021 under the symbol “GBNH”.
Greenbrook’s common shares will continue trading on the Toronto Stock Exchange in Canadian dollar currency under the symbol “GTMS”.
Further information can be found on Business Wire’s website.
Greenbrook, operating through 126 company-operated treatment centers, is a leading provider of Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States.